87 related articles for article (PubMed ID: 15373210)
1. [Regulation of human alpha-fetoprotein gene by C/EBPalpha].
Lee K
Hokkaido Igaku Zasshi; 2004 Jul; 79(4):377-87. PubMed ID: 15373210
[No Abstract] [Full Text] [Related]
2. Identification of CCAAT enhancer binding protein alpha binding sites on the human alpha-fetoprotein gene.
Li HM; Ikeda H; Nakabayashi H; Nishi S; Sakai M
Gene; 2007 Mar; 389(2):128-35. PubMed ID: 17188819
[TBL] [Abstract][Full Text] [Related]
3. CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma.
Tan EH; Hooi SC; Laban M; Wong E; Ponniah S; Wee A; Wang ND
Cancer Res; 2005 Nov; 65(22):10330-7. PubMed ID: 16288022
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
5. Functional mapping of tissue-specific elements of the human alpha-fetoprotein gene enhancer.
Nakabayashi H; Koyama Y; Suzuki H; Li HM; Sakai M; Miura Y; Wong NC; Nishi S
Biochem Biophys Res Commun; 2004 Jun; 318(3):773-85. PubMed ID: 15144905
[TBL] [Abstract][Full Text] [Related]
6. Identification of the promoter region required for human adiponectin gene transcription: Association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha.
Kita A; Yamasaki H; Kuwahara H; Moriuchi A; Fukushima K; Kobayashi M; Fukushima T; Takahashi R; Abiru N; Uotani S; Kawasaki E; Eguchi K
Biochem Biophys Res Commun; 2005 Jun; 331(2):484-90. PubMed ID: 15850785
[TBL] [Abstract][Full Text] [Related]
7. The tumour necrosis factor-alpha-mediated suppression of the CCAAT/enhancer binding protein-alpha gene transcription in hepatocytes involves inhibition of autoregulation.
Foka P; Singh NN; Salter RC; Ramji DP
Int J Biochem Cell Biol; 2009 May; 41(5):1189-97. PubMed ID: 19027873
[TBL] [Abstract][Full Text] [Related]
8. C/EBPalpha activates the transcription of triacylglycerol hydrolase in 3T3-L1 adipocytes.
Wei E; Lehner R; Vance DE
Biochem J; 2005 Jun; 388(Pt 3):959-66. PubMed ID: 15752068
[TBL] [Abstract][Full Text] [Related]
9. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
Zha S; Isaacs WB
Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
[TBL] [Abstract][Full Text] [Related]
10. CCAAT enhancer binding protein beta and hepatocyte nuclear factor 3beta are necessary and sufficient to mediate dexamethasone-induced up-regulation of alpha2HS-glycoprotein/fetuin-A gene expression.
Wöltje M; Tschöke B; von Bülow V; Westenfeld R; Denecke B; Gräber S; Jahnen-Dechent W
J Mol Endocrinol; 2006 Apr; 36(2):261-77. PubMed ID: 16595698
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes.
Chew CH; Chew GS; Najimudin N; Tengku-Muhammad TS
Int J Biochem Cell Biol; 2007; 39(10):1975-86. PubMed ID: 17616429
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
Seifeddine R; Dreiem A; Blanc E; Fulchignoni-Lataud MC; Le Frère Belda MA; Lecuru F; Mayi TH; Mazure N; Favaudon V; Massaad C; Barouki R; Massaad-Massade L
Cancer Res; 2008 Apr; 68(7):2158-65. PubMed ID: 18381421
[TBL] [Abstract][Full Text] [Related]
13. C/EBP alpha and beta mimic retinoic acid activation of IGFBP-5 in neuroblastoma cells by a mechanism independent from binding to their site.
Cesi V; Giuffrida ML; Vitali R; Tanno B; Mancini C; Calabretta B; Raschellà G
Exp Cell Res; 2005 Apr; 305(1):179-89. PubMed ID: 15777798
[TBL] [Abstract][Full Text] [Related]
14. Role of CCAAT/enhancer-binding protein, histone acetylation, and coactivator recruitment in the regulation of malic enzyme transcription by thyroid hormone.
Yin L; Wang Y; Dridi S; Vinson C; Hillgartner FB
Mol Cell Endocrinol; 2005 Dec; 245(1-2):43-52. PubMed ID: 16293364
[TBL] [Abstract][Full Text] [Related]
15. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
Jost E; do O N; Wilop S; Herman JG; Osieka R; Galm O
Leuk Res; 2009 Mar; 33(3):443-9. PubMed ID: 18757096
[TBL] [Abstract][Full Text] [Related]
16. Stable expression of C/EBPalpha in prostate cancer cells down-regulates metallothionein and increases zinc-induced toxicity.
Yin H; Smith M; Glass J
Prostate; 2005 Feb; 62(3):209-16. PubMed ID: 15389791
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
[TBL] [Abstract][Full Text] [Related]
18. Role of glucocorticoid receptor and CCAAT/enhancer-binding protein alpha in the feed-forward induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts.
Yang Z; Guo C; Zhu P; Li W; Myatt L; Sun K
J Endocrinol; 2007 Nov; 195(2):241-53. PubMed ID: 17951535
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional repression of the gluconeogenic gene PEPCK by the orphan nuclear receptor SHP through inhibitory interaction with C/EBPalpha.
Park MJ; Kong HJ; Kim HY; Kim HH; Kim JH; Cheong JH
Biochem J; 2007 Mar; 402(3):567-74. PubMed ID: 17094771
[TBL] [Abstract][Full Text] [Related]
20. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]